Categories Consumer, Earnings Call Transcripts, Preliminary Transcripts

Calavo Growers, Inc. (CVGW) Q4 2021 Earnings Call Transcript

CVGW Earnings Call - Final Transcript

Calavo Growers, Inc.  (NASDAQ: CVGW) Q4 2021 earnings call dated Mar. 14, 2022 Corporate Participants: Larry Clark — Managing Director Brian W. Kocher — President and Chief Executive Officer Mariela Matute — Chief Financial Officer Analysts:...

To read the full story, subscribe to AlphaStreet's FREE membership.

Join Now

Why FREE membership?

  • It allows you to highlight any particular content/data in the earnings call transcripts, add your insights, and share it seamlessly within your community
  • You can access preliminary earnings call transcripts during the the call, that is, in real time!
  • Track your favorite stocks and receive customized email alerts in your Inbox to keep you updated about any information regarding them

Already a member? Sign In now

Disclaimer

This transcript is produced by AlphaStreet, Inc. While we strive to produce the best transcripts, it may contain misspellings and other inaccuracies. This transcript is provided as is without express or implied warranties of any kind. As with all our articles, AlphaStreet, Inc. does not assume any responsibility for your use of this content, and we strongly encourage you to do your own research, including listening to the call yourself and reading the company’s SEC filings. Neither the information nor any opinion expressed in this transcript constitutes a solicitation of the purchase or sale of securities or commodities. Any opinion expressed in the transcript does not necessarily reflect the views of AlphaStreet, Inc.

© COPYRIGHT 2021, AlphaStreet, Inc. All rights reserved. Any reproduction, redistribution or retransmission is expressly prohibited.

Most Popular

Cost reduction has become a priority for FedEx (FDX) after a challenging quarter

Shares of FedEx Corporation (NYSE: FDX) were up 1% on Tuesday. The stock has dropped 44% year-to-date and 34% over the past 12 months. The company delivered mixed results for

Prime Medicine is the next big biotech to pursue IPO. Here’s all you need to know

After a soft start to the year, the IPO market has witnessed muted activity so far though a few big companies entered the stock market. On the heels of AIG

Stock Watch: Is Darden Restaurants a good buy after earnings?

After a prolonged slowdown, the restaurant industry is returning to normal patterns but macroeconomic uncertainties and high inflation are currently playing spoilsport for it. While the pandemic-related slump forced many

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top